Neuropsychological effects of levetiracetam and carbamazepine in children with focal epilepsy

Neurology

Volumn 84, Issue 23, 2015, Pages 2312-2319

  Jung, Da Eun ^a   Yu, Rita ^c   Yoon, Jung Rim ^c   Eun, Baik Lin ^d   Kwon, Soon Hak ^e   Lee, Yun Jin ^f   Eun, So Hee ^d   Lee, Joon Soo ^c   Kim, Heung Dong ^c   Nam, Sang Ook ^f   Kim, Gun Ha ^d   Hwang, Su Kyeong ^e   Eom, Soyong ^c   Kang, Dae Ryong ^b   Kang, Hoon Chul ^c  

^a UMHC   (United States)

^b Ajou University School of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Korea University   (South Korea)

^e Kyungpook National University School of Medicine   (South Korea)

^f Pusan National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; ETIRACETAM; ANTICONVULSIVE AGENT; PIRACETAM;

ADOLESCENT; ADVERSE OUTCOME; CHILD; CHILD BEHAVIOR CHECKLIST; COGNITION ASSESSMENT; CONFERENCE PAPER; CONTROLLED STUDY; DEPRESSION INVENTORY; DRUG EFFICACY; DRUG TOLERABILITY; FOCAL EPILEPSY; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MONOTHERAPY; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; SOMNOLENCE; TREATMENT OUTCOME; ANALOGS AND DERIVATIVES; CHILD BEHAVIOR; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECTS; EPILEPSIES, PARTIAL; FEMALE; FOLLOW UP; INTELLIGENCE; MALE; PRESCHOOL CHILD; SOCIAL ADAPTATION;

ADOLESCENT; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; CHILD BEHAVIOR; CHILD, PRESCHOOL; EPILEPSIES, PARTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTELLIGENCE; MALE; PIRACETAM; SOCIAL SKILLS; TREATMENT OUTCOME;

EID: 84930704306     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001661     Document Type: Conference Paper

References (39)

1. Berg AT, Langfitt JT, Testa FM, et al. Global cognitive function in children with epilepsy: a community-based study. Epilepsia 2008;49:608-614.
2. Holmes GL. Epilepsy in the developing brain: lessons from the laboratory and clinic. Epilepsia 1997;38:12-30.
3. Bootsma HPR, Aldenkamp AP, Diepman L, et al. The effect of antiepileptic drugs on cognition: patient perceived cognitive problems of topiramate versus levetiracetam in clinical practice. Epilepsia 2006;47:24-27.
4. Gomer B, Wagner K, Frings L, et al. The influence of antiepileptic drugs on cognition: a comparison of levetiracetam with topiramate. Epilepsy Behav 2007;10: 486-494.
5. Meador K, Gevins A, Loring D, et al. Neuropsychological and neurophysiologic effects of carbamazepine and levetiracetam. Neurology 2007;69:2076-2084.
6. Lagae L. Cognitive side effects of anti-epileptic drugs: the relevance in childhood epilepsy. Seizure 2006;15: 235-241.
7. Loring DW, Marino S, Meador KJ. Neuropsychological and behavioral effects of antiepilepsy drugs. Neuropsychol Rev 2007;17:413-425.
8. Cereghino J, Biton V, Abou-Khalil B, Dreifuss F, Gauer L, Leppik I. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial. Neurology 2000; 55:236-242.
9. Chaisewikul R, Privitera M, Hutton J, Marson A. Levetiracetam add-on for drug-resistant localization related (partial) epilepsy. Cochrane Database Syst Rev 2001;1: CD001901.
10. Khurana DS, Kothare SV, Valencia I, Melvin JJ, Legido A. Levetiracetam monotherapy in children with epilepsy. Pediatr Neurol 2007;36:227-230.
11. Koukkari MW, Guarino EJ. Retrospective study of the use of levetiracetam in childhood seizure disorders. J Child Neurol 2004;19:944-947.
12. Bello-Espinosa LE, Roberts SL. Levetiracetam for benign epilepsy of childhood with centrotemporal spikes: three cases. Seizure 2003;12:157-159.
13. Lagae L, Buyse G, Ceulemans B. Clinical experience with levetiracetam in childhood epilepsy: an add-on and monotherapy trial. Seizure 2005;14:66-71.
14. Engelberts NH, Klein M, van der Ploeg HM, Heimans JJ, Jolles J, Kasteleijn-Nolst Trenite DG. Cognition and health-related quality of life in chronic well-controlled patients with partial epilepsy on carbamazepine monotherapy. Epilepsy Behav 2002;3:316-321.
15. Prevey ML, Delaney RC, Cramer JA, Cattanach L, Collins JF, Mattson RH. Effect of valproate on cognitive functioning: comparison with carbamazepine: The Department of Veterans Affairs Epilepsy Cooperative Study 264 Group. Arch Neurol 1996;53:1008-1016.
16. Drane DL, Meador KJ. Epilepsy, anticonvulsant drugs and cognition. Baillieres Clin Neurol 1996;5:877-885.
17. Devinsky O. Cognitive and behavioral effects of antiepileptic drugs. Epilepsia 1995;36(suppl 2):S46-S65.
18. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010;51:676-685.
19. Kwak K, Park H, Kim C. The Manual for the Korean WISC-III. Seoul: The Special Education; 2002.
20. Kwak K, Park H, Kim C. A study for the standardization of Korean WISC-3 (1). Korean J Dev Psychol 2002;15: 19-33.
21. Park H, Kwak K, Park K. Korean-Wechsler Preschool and Primary Scale of Intelligence (K-WPPSI). Seoul: Special Education Co.; 1996.
22. Kim J-M, Sung O-R, Hyun M-H. The Validity study of Parent-Child Interaction rating scales (MBRS & CBRS). Korean J Clin Psychol 2000;19:895-901.
23. Oh K, Lee H, Hong K, Ha E. Korean Child Behavior Checklist. Seoul: Chung Ang Aptitude; 1997.
24. Kovacs M. Children's Depression Inventory (CDI). Toronto: Multi-Health Systems Inc.; 2004.
25. Reynolds CR, Richmond BO. Revised Children's Manifest Anxiety Scale (RCMAS): Manual. Torrance, CA: Western Psychological Services; 1985.
26. Austin JK, Harezlak J, Dunn DW, Huster GA, Rose DF, Ambrosius WT. Behavior problems in children before first recognized seizures. Pediatrics 2001;107:115-122.
27. Ettinger AB, Weisbrot DM, Nolan EE, et al. Symptoms of depression and anxiety in pediatric epilepsy patients. Epilepsia 1998;39:595-599.
28. Kang HC, Eun BL, Wu Lee C, et al. The effects on cognitive function and behavioral problems of topiramate compared to carbamazepine as monotherapy for children with benign rolandic epilepsy. Epilepsia 2007;48:1716-1723.
29. Eun S-H, Eun B-L, Lee JS, et al. Effects of lamotrigine on cognition and behavior compared to carbamazepine as monotherapy for children with partial epilepsy. Brain Dev 2012;34:818-823.
30. Gottfredson LS. Logical fallacies used to dismiss the evidence on intelligence testing. In: Phelps RP. Correcting Fallacies about Educational and Psychological Testing. Washington, DC: American Psychological Association; 2009.
31. Levisohn PM, Mintz M, Hunter SJ, Yang H, Jones J; Levetiracetam Study Group. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial. Epilepsia 2009;50:2377-2389.
32. Glauser TA. Effects of antiepileptic medications on psychiatric and behavioral comorbidities in children and adolescents with epilepsy. Epilepsy Behav 2004;5(suppl 3): S25-S32.
33. Motamedi G, Meador K. Epilepsy and cognition. Epilepsy Behav 2003;4:25-38.
34. Meador KJ, Loring DW, Huh K, Gallagher B, King D. Comparative cognitive effects of anticonvulsants. Neurology 1990;40:391-394.
35. Abou-Khalil B. Benefit-risk assessment of levetiracetam in the treatment of partial seizures. Drug Safety 2005;28: 871-890.
36. Cramer JA, De Rue K, Devinsky O, Edrich P, Trimble MR. A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials. Epilepsy Behav 2003;4:124-132.
37. Mula M, Trimble M, Yuen A, Liu R, Sander J. Psychiatric adverse events during levetiracetam therapy. Neurology 2003;61:704-706.
38. Dodrill CB, Troupin AS. Neuropsychological effects of carbamazepine and phenytoin A reanalysis. Neurology 1991;41:141-143.
39. Placidi GF, Lenzi A, Lazzerini F, Cassano GB, Akiskal H. The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients. J Clin Psychiatry 1986;47:490-494.